PharmiWeb Today Story
STRASBOURG, France and BERLIN, Germany, November 05, 2024 / Biotech Newswire / -- Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and ProBioGen, a leading CDMO in biologics, vaccines and viral vectors, announce that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX® suspension cell line. This partnership aims to add value by combining ProBioGen’s specific production technology with the manufacturing capabilities of Transgene’s individualized cancer vaccine program and its myvac® platform.
ProBioGen’s AGE1.CR.pIX suspension cell line showcases innovation and reliability in bioprocessing with a proven track record and is currently in use for multiple late-stage clinical trials. Renowned for its high yield and scalability, this platform enables efficient industrial manufacturing processes, translating into cost-effectiveness and increased productivity in manufacturing. Additionally, the AGE1.CR.pIX cell line offers robust growth and excellent genetic stability to ensure consistent and reliable production.
“We are delighted to embark on this collaborative journey with ProBioGen,” said Dr. Alessandro Riva, CEO of Transgene. “The AGE1.CR.pIX suspension cell line represents a significant addition to further expand the manufacturing processes for our individualized cancer vaccines while we work towards providing patients with tailored patient-specific therapies against cancer on a larger scale.”
The partnership between Transgene…
Read More...Articles
How to Actually Network at an Industry Event
28-Oct-2024
How AI is Impacting Graduate Recruitment
23-Oct-2024
Trick or Treat: Spotting Red Flags in Job Offers
15-Oct-2024
Featured Events
-
Pharmaceutical Manufacturing & Packaging Congress…
28-Jun-2021 - 29-Jun-2021 -
6th CAR-TCR Summit
30-Aug-2021 - 02-Sep-2021 -
1st International Conference “WE! are the Clinical…
18-Sep-2021 - 18-Sep-2021 -
Reuters Events: Pharma 2022
11-Oct-2022 - 13-Oct-2022 -
AI in Healthcare Summit Boston 2022
13-Oct-2022 - 14-Oct-2022 -
Reuters Events: Pharma 2023
18-Apr-2023 - 20-Apr-2023
News
-
Aytu BioPharma to Report Fiscal 2025 First Quarter…
06-Nov-2024 -
Ainos Reports Third Quarter 2024 Financial Results…
06-Nov-2024 -
Nyxoah Reports Third Quarter Financial and Operati…
06-Nov-2024 -
Amphastar Pharmaceuticals Reports Financial Result…
06-Nov-2024 -
OptiMed Health Partners Earns ACHC Accreditation O…
06-Nov-2024 -
FDA Approves Renewal of Canalevia-CA1, Jaguar Heal…
06-Nov-2024